Basic Information
Latuda
Regulatory Information
EMEA/H/C/002713
Authorised
March 21, 2014
January 22, 2014
27
December 13, 2024
Company Information
Italy
Viale Amelia 70 00181 Roma
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of schizophrenia in adults aged 18 years and over.
Overview Summary
Latuda is a medicine that is used to treat patients from 13 years of age with schizophrenia, a mental illness with symptoms that include disorganised thinking and speech, hallucinations (hearing or seeing things that are not there), suspiciousness and delusions (mistaken beliefs). Latuda contains the active substance lurasidone.